Exploitation of conserved eukaryotic host cell farnesylation machinery by an F-box effector of Legionella pneumophila by Price, Christopher T.D. et al.
Article
The Rockefeller University Press  $30.00
J. Exp. Med. Vol. 207 No. 8  1713-1726
www.jem.org/cgi/doi/10.1084/jem.20100771
1713
Exploitation of eukaryotic cellular processes is 
essential for intracellular proliferation of intra-
cellular microbial pathogens. The Legionnaires’ 
disease–causing bacterium, Legionella pneumophila, 
replicates within alveolar macrophages, causing 
pneumonia (Isberg et al., 2009). The organism 
is  transmitted  to  humans  from  the  aquatic   
environment where L. pneumophila replicates 
within amoeba and ciliates (Molmeret et al., 
2005; Franco et al., 2009).
Coevolution and adaptation of L. pneumoph-
ila to the intracellular lifestyle within amoeba in 
the aquatic environment is believed to have played 
a major role in its ability to exploit evolution-
arily conserved eukaryotic processes that enable its 
proliferation within human alveolar macrophages 
(Molmeret  et  al.,  2005;  Franco  et  al.,  2009). 
Within both evolutionarily distant host cells, 
L. pneumophila evades endocytic fusion and inter-
cepts ER to Golgi vesicle traffic to remodel its 
phagosome into an ER-derived vacuole (Kagan 
and Roy, 2002; Molmeret et al., 2005; Shin and 
Roy, 2008; Isberg et al., 2009). The Dot/Icm 
type IV secretion system (Segal et al., 1998; Vogel 
et al., 1998) injects into the host cell a cadre of 
200 effectors to modulate a myriad of cellular 
processes to reprogram the host cell into a prolif-
eration niche (de Felipe et al., 2008; Shin and 
Roy, 2008; Isberg et al., 2009). The Ankyrin B 
(AnkB) effector is injected into the host cell by the 
Dot/Icm system upon bacterial attachment to the 
plasma membrane and exploits an evolutionarily 
conserved eukaryotic machinery within mamma-
lian and protozoan cells (Price et al., 2009).
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Farnesylation involves covalent linkage of eukaryotic proteins to a lipid moiety to anchor 
them into membranes, which is essential for the biological function of Ras and other 
proteins. A large cadre of bacterial effectors is injected into host cells by intravacuolar 
pathogens through elaborate type III–VII translocation machineries, and many of these 
effectors are incorporated into the pathogen-containing vacuolar membrane by unknown 
mechanisms. The Dot/Icm type IV secretion system of Legionella pneumophila injects into 
host cells the F-box effector Ankyrin B (AnkB), which functions as platforms for the dock-
ing of polyubiquitinated proteins to the Legionella-containing vacuole (LCV) to enable 
intravacuolar proliferation in macrophages and amoeba. We show that farnesylation of 
AnkB is indispensable for its anchoring to the cytosolic face of the LCV membrane, for its 
biological function within macrophages and Dictyostelium discoideum, and for intrapulmo-
nary proliferation in mice. Remarkably, the protein farnesyltransferase, RCE-1 (Ras-converting 
enzyme-1), and isoprenyl cysteine carboxyl methyltransferase host farnesylation enzymes 
are recruited to the LCV in a Dot/Icm-dependent manner and are essential for the biologi-
cal function of AnkB. In conclusion, this study shows novel localized recruitment of the 
host farnesylation machinery and its anchoring of an F-box effector to the LCV membrane, 
and this is essential for biological function in vitro and in vivo.
© 2010 Price et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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RESULTS
Localization of ectopically expressed AnkB to the plasma 
membrane of mammalian cells and D. discoideum  
is mediated by its C-terminal CaaX motif
Microscopic analyses showed that ectopically expressed 3xFlag 
AnkB in HEK293 cells and in D. discoideum exhibits a striking lo-
calization at the cell periphery (Fig. 1 A and Fig. S1; Price et al., 
2009). In silico analysis of AnkB revealed that the last C-terminal 
4 aa residues (169CVLC) constitute a potential eukaryotic CaaX 
motif. To examine whether localization of AnkB to the cell   
periphery/plasma membrane was caused by farnesylation, a 
substitution (cysteine to alanine) mutant allele (ankB169C/A) was 
The Dot/Icm-translocated AnkB effector is a noncanoni-
cal F-box protein that harbors two eukaryotic-like Ankyrin 
domains (ANK) that are thought to be involved in protein–
protein interaction and is highly regulated by the growth 
phase (Al-Khodor et al., 2008, 2010a,b; Habyarimana et al., 
2008). The F-box domain of AnkB interacts with the host 
SKP1 component of the SCF1 ubiquitin ligase complex and 
functions as a platform for the docking of polyubiquitinated 
proteins to the Legionella-containing vacuole (LCV) mem-
brane within primary human macrophages, the U937 human 
macrophage cell line, HEK293 cells, Acanthamoeba polyphaga, 
and Dictyostelium discoideum (Dorer et al., 2006; Price et al., 
2009). The AnkB effector is essential for proliferation of 
L. pneumophila within the two evolutionarily distant hosts, 
mammalian and protozoan cells, and for intrapulmonary bac-
terial proliferation and manifestation of pulmonary disease in 
the mouse model (Al-Khodor et al., 2008; Price et al., 2009). 
Importantly, the F-box domain as well as the two ankyrin 
protein–protein interaction domains are all essential for the 
biological function of AnkB (Al-Khodor et al., 2008; Price   
et al., 2009, 2010).
Prenylation  is  a  highly  conserved  posttranslation  lipid 
modification of eukaryotic proteins that confers hydropho-
bicity on the modified protein and its targeting to membranes 
(Wright and Philips, 2006). Prenylation is mediated by pro-
tein geranylgeranyltransferase I (PGGT), protein farnesyl-
transferase  (PFT),  or  by  Rab  geranylgeranyltransferase 
(Wright and Philips, 2006). This posttranslational modifica-
tion plays a key role in the functional activity of numerous 
eukaryotic proteins, including Rab proteins, Ras, G proteins, 
and protein kinases (Casey et al., 1989; Hancock et al., 1989; 
Mumby et al., 1990; Yamane et al., 1990; Wang et al., 1992). 
Prenylation involves the covalent addition of either a 15-carbon 
farnesyl or a 20-carbon geranylgeranyl isoprenoid moiety at a 
cysteine  residue  in  a  conserved  C-terminal  tetrapeptide 
CaaX motif. After farnesylation of the conserved cysteine 
residue of the CaaX motif, the terminal -aaX tripeptide is 
often  cleaved  by  the  RCE-1  (Ras-converting  enzyme-1) 
protease in the ER membrane (Boyartchuk et al., 1997). 
Then the C-terminal farnesylated cysteine is methylated 
by isoprenyl cysteine carboxyl methyltransferase (ICMT; Dai 
et al., 1998; Bergo et al., 2000).
A myriad of effectors is injected into the host cell by 
elaborate type III–VII translocation systems of intravacuolar 
pathogens. Although many injected bacterial effectors are 
anchored into the pathogen-containing vacuolar membrane 
of intracellular pathogens, the mechanism of this anchoring 
is not well understood. Our data show that host cell farne-
sylation of AnkB anchors it to the membrane of the LCV 
and that the three host enzymes involved in farnesylation are 
recruited to the LCV in a Dot/Icm-dependent manner and 
are essential for the biological function of AnkB, which is 
novel. Farnesylation of AnkB is indispensable in vivo where 
the defect in farnesylation results in total attenuation in   
intrapulmonary proliferation in mice, similar to the genetic 
ablation of ankB.
Figure 1.  Ectopically expressed 3xFlag AnkB is farnesylated and is 
targeted to the plasma membrane. (A) Representative confocal micros-
copy images of cells ectopically expressing 3xFlag-tagged AnkB, AnkB169C/A, 
and BAP. Green indicates labeling with anti-Flag antibody, whereas red 
indicates labeling with antifarnesyl antibody, and the nucleus is stained 
blue (DAPI). The arrowheads indicate strong colocalization of AnkB with 
farnesylation at the plasma membrane. (B) Transfected HEK293 cells  
expressing 3xFlag-tagged proteins were lysed, immunoprecipitated with 
an anti-Flag antibody, and immunoblotted with antifarnesyl and anti-Flag 
antibodies. (C) Partitioning of 3xFlag AnkB in the detergent or aqueous 
phases of Triton X-114. Transfected cells were lysed with Triton X-114  
and separated into detergent (D)-soluble and aqueous (Aq) phases.  
Samples were then analyzed by immunoblotting with anti-Flag antibodies. 
All experiments were performed three times, and representative  
examples are shown.JEM VOL. 207, August 2, 2010 
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were pretreated with the farnesyltransferase or geranylgeranyl-
transferase  inhibitors  FTI-277  or  GGTI-298,  respectively 
(Lerner et al., 1995; McGuire et al., 1996), and analyzed by 
confocal microscopy. At all concentrations used in this study, 
neither FTI-277 nor GGTI-298 affected viability of HEK293 
cells, as determined by trypan blue exclusion (unpublished data). 
The data showed that the farnesyltransferase inhibitor FTI-277 
blocked membrane localization of AnkB at all concentrations 
above 10 nM up to 20 µM (Fig. 2 D). At a concentration of   
10 nM, there was partial inhibition of membrane localization of 
AnkB, whereas at 5 nM, the inhibitor had no effect on mem-
brane localization of AnkB (Fig. 2 D). In contrast, GGTI-298 
blocked membrane localization of AnkB only at high con-
centrations of at least 10 µM (Fig. 2 D). To confirm these 
observations, we analyzed farnesylation of 3xFlag AnkB immu-
noprecipitated from transfected HEK293 cells treated with 
and without FTI-277 or GGTI-298, followed by immuno-
blotting with antifarnesyl antibody (Fig. 2 E). The data showed 
that treatment with 0.5–20 µM FTI-277 or 20 µM GGTI-298 
blocked  recognition  of  AnkB  by  the  antifarnesyl  antibody, 
compared with untreated cells (Fig. 2 E). In cells treated with 
0.5 µM GGTI-298, AnkB was recognized by the antifarnesyl 
antibody, which is consistent with its membrane localization 
during treatment by that concentration (Fig. 2, D and E).
To confirm our chemical approach of inhibition of farnesyl-
transferase, we used farnesyltransferase-specific RNA inter-
ference  (RNAi)  to  silence  expression  of  the    subunit  of 
farnesyltransferase (FT-), the enzyme responsible for farne-
sylation of the cysteine residue within the CaaX motif (Reiss   
et al., 1990; Moores et al., 1991). Immunoblot analysis con-
firmed knockdown of FT- expression by 48 h after treatment 
of HEK293 cells by RNAi without any detectable effect on 
viability (Fig. 2 G). Silencing FT- in cells ectopically expressing 
3xFlag-tagged AnkB and BAP4CaaX resulted in a dramatic re-
distribution of AnkB and BAP4CaaX from the plasma membrane 
into the cytosol (Fig. 2 F). In untreated cells, or in cells treated 
with a scrambled RNAi control, the AnkB and BAP4CaaX pro-
teins remained associated with the plasma membrane (Fig. 2 F). 
To confirm that silencing the expression of FT- inhibited 
farnesylation, immunoprecipitation followed by immunoblot-
ting were performed (Fig. 2 H). Silencing FT- resulted in the 
inability of AnkB to bind the antifarnesyl antibody (Fig. 2 H). 
As expected, in untreated cells or cells treated with control 
RNAi, AnkB bound the antifarnesyl antibody (Fig. 2 H). 
Chemical inhibition or RNA-mediated knockdown of the 
host farnesylation machinery likely inhibited several trafficking 
pathways such as Rab localization to membranes. Collectively, 
the data show that the host farnesyltransferase is essential for 
farnesylation of AnkB on the C-terminal eukaryotic CaaX 
motif, resulting in its anchoring to the host membranes.
Farnesylation by macrophages and D. discoideum anchors 
AnkB to the cytosolic face of the LCV membrane
We used confocal microscopy to determine cellular location 
of AnkB at 2 h after infection of U937 macrophages and 
D.  discoideum  using  rabbit  anti-AnkB  antiserum.  Our  data 
generated. The 3xFlag-tagged AnkB, AnkB169C/A, or the con-
trol bacterial alkaline phosphatase (BAP) was ectopically ex-
pressed in HEK293 cells. Cell lysates were immunoprecipitated 
with anti-Flag antibody, and the immunoprecipitate was sub-
jected to immunoblotting probed with anti-Flag followed by 
antifarnesyl antibody. The antifarnesyl antibody bound AnkB 
but not the AnkB169C/A variant or the BAP negative control 
(Fig. 1 B). Examination by confocal microscopy showed that in 
contrast to AnkB, AnkB169C/A was not localized to the plasma 
membrane  but  was  distributed  throughout  the  cytosol  of 
HEK293 cells and D. discoideum (Fig. 1 A and Fig. S1). In addi-
tion, an intense colocalization of farnesylation with AnkB but not 
AnkB169C/A or BAP was evident in HEK293 cells (Fig. 1 A).
Farnesylation of AnkB confers hydrophobicity
Because of hydrophobicity, farnesylated proteins partition into 
the detergent phase in Triton X-114 extractions (Bordier, 1981). 
Therefore, lysates of HEK293 cells ectopically expressing 
3xFlag-tagged AnkB, AnkB169C/A, or BAP control were solu-
bilized with Triton X-114. The data showed that AnkB parti-
tioned solely into the detergent phase, whereas AnkB169C/A 
partitioned solely into the aqueous phase, similar to the cytosolic 
protein BAP (Fig. 1 C). Collectively, AnkB is farnesylated on 
the cysteine residue of the C-terminal CaaX motif, resulting in 
an increase in hydrophobicity and integration of AnkB into cel-
lular membranes.
The CaaX motif of AnkB is sufficient for targeting a cytosolic 
protein to the plasma membrane
To determine whether the CaaX motif (CVLC) of AnkB was 
sufficient for targeting a cytosolic protein to the plasma mem-
brane, we generated in-frame fusions of the last 12, 8, and 4 aa 
residues of AnkB to the C terminus of 3xFlag BAP (BAP12CaaX, 
BAP8CaaX, and BAP4CaaX) and transfected HEK293. The data 
showed that although the native BAP was diffusely distributed 
throughout the cytosol, all of the three BAP12CaaX, BAP8CaaX, 
and BAP4CaaX hybrid proteins localized primarily to the plasma 
membrane, similar to AnkB (Fig. 2 A). In Triton X-114, 52% 
of BAP4CaaX partitioned into the detergent phase, whereas native 
BAP partitioned exclusively into the aqueous phase (Fig. 2 B).
To confirm the aforementioned data, lysates of transfected 
HEK293 cell expressing 3xFlag-tagged BAP or BAP4CaaX were   
immunoprecipitated with anti-Flag antibody, and the immuno-
precipitate was subjected to immunoblotting probed with anti-
Flag followed by antifarnesyl antibody. The data showed that 
similar to AnkB, BAP4CaaX but not BAP was recognized by the 
antifarnesyl antibody (Fig. 2 C). Therefore, the CaaX farne-
sylation motif of AnkB is sufficient for targeting a cytosolic pro-
tein to cellular membranes through farnesylation and subsequent 
increase in hydrophobicity of the modified protein.
Host cell farnesyltransferase is essential for targeting AnkB 
to host membranes
We determined the effect of chemical inhibition of host 
prenylation enzymes on targeting of AnkB to the plasma 
membrane. The HEK293 cells transfected with 3xFlag AnkB 1716 Host farnesylation of a Legionella effector | Price et al.
Figure 2.  Host farnesyltransferase modifies ectopically expressed 3xFlag-tagged AnkB and BAP4CaaX through the addition of a farnesyl  
moiety. (A) Representative confocal microscopy images of cells transfected with 3xFlag-tagged BAP, BAP12CaaX, BAP8CaaX, and BAP4CaaX. The cells were la-
beled with anti-Flag antibody (green), whereas the nucleus is stained with DAPI (blue). Arrowheads indicate localization of the proteins to the plasma 
membrane. (B) Partitioning of 3xFlag-tagged BAP4CaaX in Triton X-114 detergent (D) or aqueous (Aq) phases. Transfected cells were lysed with Triton X-114 
and separated into detergent-soluble and aqueous phases. Samples were then analyzed by immunoblotting with anti-Flag antibodies. (C) 3xFlag-tagged 
BAP and BAP4CaaX were immunoprecipitated from transfected HEK293 cells with anti-Flag resin and then analyzed by immunoblotting (IB) with antifarnesyl 
and anti-Flag antibodies. (D) Representative confocal images of HEK293 cells transfected with 3xFlag AnkB and treated with FTI-277 or GGTI-298 at con-
centrations of 0–20 µM. Anti-Flag labeling is represented in green, whereas the nucleus is stained blue (DAPI). Arrowheads indicate localization at the 
plasma membrane. All experiments were performed three times, and representative examples are shown. (E) Ectopically expressed 3xFlag AnkB in HEK293 
cells treated with and without FTI-277 or GGTI-298 was immunoprecipitated with anti-Flag resin and then analyzed by immunoblotting with anti-Flag 
followed by antifarnesyl antibodies. (F) Knockdown expression of FT- by RNAi blocks targeting of ectopically expressed 3xFlag-tagged AnkB and BAP4CaaX 
to the plasma membrane. Representative confocal microscopy images of transfected untreated HEK293 cells or treated with scrambled control or FT-–
specific RNAi. Anti-Flag labeling is represented in green, whereas the nucleus is stained blue (DAPI). Arrowheads indicate localization of Flag-tagged  
proteins at the plasma membrane. (G) HEK293 cell lysates were immunoblotted with an anti–FT- antibody followed by antiactin antibody. (H) Lysates of 
RNAi-treated HEK293 cells expressing 3xFlag AnkB were immunoprecipitated by anti-Flag antibodies, followed by immunoblotting with anti-Flag  
followed by antifarnesyl antibodies. All experiments were performed three times, and representative examples are shown.JEM VOL. 207, August 2, 2010 
Article
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AnkB169C/A or the dotA translocation-defective mutant that 
is unable to translocate AnkB or other effectors (Fig. 3 F). 
Therefore, during infection, translocated AnkB localized to 
the LCV membrane is farnesylated, which is essential for its 
anchoring to the cytosolic face of the LCV membrane.
We investigated the potential of exploitation of the host 
farnesylation machinery by 20 bacterial pathogens and an endo-
symbiont that inject effectors into host cells by elaborate type 
III–VII  secretion  systems.  Few  housekeeping  proteins  con-
tained the CaaX motif in most bacteria examined, and these 
were excluded from our analyses because they are unlikely to 
be effectors injected into the host cell. Interestingly, in silico 
genomic analyses have shown that all of these pathogens en-
code one or several C-terminal CaaX motif–containing pro-
teins, compared with the genomes of nonpathogenic bacteria 
that have none, and some of these proteins are already docu-
mented effectors (Table S1), but the rest are of unknown func-
tion. In contrast, there were no CaaX motif–containing proteins 
encoded by the genomes of Staphylococcus aureus, Streptococcus 
mutans, Corynebacterium diphtheriae, or nonpathogenic Escherichia 
coli and Bacillus subtilis. Therefore, there is the potential of a 
widespread paradigm of exploitation of host cell farnesylation 
by bacterial pathogens that inject effectors into the host cell.
The CaaX motif of AnkB is indispensable  
for polyubiquitination of the LCV within macrophages  
and D. discoideum
To determine the functional role of farnesylation of AnkB dur-
ing infection, we determined whether the C-terminal CaaX 
motif of AnkB was required for the docking of polyubiqui-
tinated proteins to the LCV (Price et al., 2009). To test this, we 
infected U937 human macrophages and D. discoideum with the 
WT strain, the ankB-null mutant, or the ankB mutant comple-
mented with the WT allele of ankB or the ankB169C/A allele 
(Fig. 4, A and B). The infection was performed for 1 h at a 
multiplicity of infection (MOI) of 10, followed by 1-h treat-
ment with gentamicin to kill extracellular bacteria. Essentially, 
similar results were found in human macrophages and D. dis-
coideum (Fig. 4, A and B). After 2 h of infection, 90% of 
LCVs containing WT bacteria were decorated with polyubiq-
uitinated proteins (Fig. 4 A), compared with only 20% of the 
LCVs harboring the ankB mutant (Fig. 4 A). The defect in 
polyubiquitination of the LCVs harboring the ankB mutant 
was completely restored by complementation with the WT 
ankB allele (Fig. 4, A and B). Importantly, LCVs harboring the 
ankB mutant complemented with the ankB169C/A allele failed 
to be decorated with polyubiquitinated proteins, similar to 
the ankB-null mutant (Fig. 4, A and B). Therefore, farnesylation 
of AnkB is essential for its biological function as a platform for 
the docking of polyubiquitinated proteins to the LCV within 
human macrophages and D. discoideum.
The CaaX motif of AnkB is indispensable for intravacuolar 
proliferation within macrophages and D. discoideum
We determined the role of the CaaX motif in intravacuolar 
proliferation of the pathogen. Essentially, similar results were 
showed localization of AnkB to the LCV harboring the WT 
strain in both macrophages and D. discoideum (Fig. 3 A and 
Fig. S2) but not the ankB mutant (Fig. 3 A). There was some 
background staining with anti-AnkB in the cytosol of nonin-
fected  and  ankB  mutant–infected  U937  macrophages  but 
none in D. discoideum. Therefore, AnkB seems to be exclu-
sively localized to the LCV.
Next, we analyzed whether AnkB was located within the 
lumen of the LCV or on the cytosolic face of the LCV mem-
brane. The LCVs were isolated at 2 h after infection of U937 
macrophages and D. discoideum and probed with anti-AnkB 
antiserum before and after permeabilization of the LCV. The 
SidC effector that is known to localize to the cytosolic face of 
the LCV membrane was used as a positive control (Luo and 
Isberg, 2004). To ensure integrity of the isolated LCV prepara-
tions, we labeled nonpermeabilized LCVs with mouse anti– 
L. pneumophila monoclonal antibody, and after permeabilization 
with rabbit anti–L. pneumophila antiserum (Fig. 3 B). Our data 
showed that 95% of nonpermeabilized LCVs did not bind 
the mouse anti–L. pneumophila antibody, indicating that the 
isolation procedure did not disrupt the integrity of the LCV 
membrane (Fig. 3 B). When the LCVs were permeabilized 
before probing with both antibodies, both probes bound 
95% of the bacteria within the LCVs (Fig. 3 C).
The data showed that before permeabilization, WT strain–
containing purified LCVs from U937 macrophages and D. dis-
coideum bound the anti-AnkB antibody, similar to the SidC 
positive control (Fig. 3 D and Fig. S2). Before permeabilization, 
the LCVs of the ankB mutant expressing AnkB169C/A isolated 
from macrophages and D. discoideum did not bind the anti-AnkB 
antiserum (Fig. 3 D and Fig. S2) but did after permeabilization 
(Fig. 3 E and Fig. S2). We used the dotA mutant as a control be-
cause it expresses all effectors but is unable to translocate them 
because of the defect in the DotA structural component of the 
Dot/Icm translocation apparatus. As expected, nonpermeabi-
lized LCVs harboring the translocation-defective dotA mutant 
(which expresses but does not translocate effectors) did not bind 
the anti-AnkB or anti-SidC antiserum (Fig. 3 D and Fig. S2). 
After permeabilization, the dotA mutant bound the anti-AnkB 
and anti-SidC antiserum within the LCVs as expected (Fig. 3 E). 
Both permeabilized and nonpermeabilized LCVs harboring the 
ankB mutant failed to bind the anti-AnkB antiserum (Fig. 3, 
D and E; and Fig. S2). Importantly, inhibition of farnesyltrans-
ferase blocked anchoring of AnkB to the cytosolic face of the 
LCV membrane (Fig. 3 G). This indicates that farnesylation of 
the conserved cysteine residue within the C-terminal CaaX 
motif is essential for anchoring AnkB to the cytosolic face of the 
LCV membrane within macrophages and D. discoideum.
To confirm farnesylation of AnkB localized to the LCV 
membrane, purified LCVs from infected U937 macrophages 
were subjected to immunoprecipitation using anti-AnkB 
antiserum, followed by immunoblotting probed with anti-
AnkB followed by antifarnesyl antibody. The data showed 
that the AnkB derived from LCVs harboring WT bacteria 
was  farnesylated  (Fig.  3  F).  In  contrast,  AnkB  was  not 
farnesylated in LCVs harboring L. pneumophila expressing 1718 Host farnesylation of a Legionella effector | Price et al.
allele restored replication, similar to the WT strain (Fig. 4 C). 
In contrast, complementation of the ankB mutant with the 
ankB169C/A allele failed to restore intracellular replication to 
the  ankB  mutant  within  macrophages  and  D.  discoideum. 
Therefore, the C-terminal CaaX motif of AnkB is essential 
found in U937 macrophages and D. discoideum (Fig. 4, C and D). 
The data showed that the WT strain proliferated robustly 
within macrophages and D. discoideum, whereas the ankB 
mutant was defective in intracellular proliferation (Fig. 4 C). 
Complementation of the ankB mutant with the WT ankB 
Figure 3.  AnkB localizes to the LCV mem-
brane through farnesylation of its CaaX 
motif. (A) The U937 cells and D. discoideum 
were infected and analyzed at 2 h by confocal 
microscopy using anti–L. pneumophila (Lpn) 
antibodies (green) and anti-AnkB antisera (red). 
Arrowheads indicate localization of AnkB with 
L. pneumophila. (B and C) Integrity of the mem-
brane of purified LCVs from U937 cells was veri-
fied by labeling with mouse anti–L. pneumophila 
monoclonal antibody before permeabilization 
of the LCVs. After permeabilization, the LCVs 
were probed with rabbit anti–L. pneumophila 
antiserum to visualize the bacteria within the 
LCVs. (D and E) AnkB localizes to the cytosolic 
side of the LCV membrane. (D) The LCVs harbor-
ing the indicated strains were probed with anti-
AnkB or anti-SidC antiserum before 
permeabilization (red) to determine whether 
the protein was localized to the cytosolic side 
of the LCV membrane. After permeabilization, 
the LCVs were probed with mouse anti– 
L. pneumophila monoclonal antibodies (green) 
to visualize the bacteria within the LCV. Quanti-
tation is shown in the merged panels, where the 
numbers represent the percentage plus stan-
dard deviation of LCVs that bound anti-AnkB or 
anti-SidC antiserum before permeabilization. 
Analyses were based on the examination of 100 
LCVs from triplicate samples. (E) The LCVs were 
permeabilized and then labeled with anti-AnkB 
or anti-SidC antiserum and anti–L. pneumophila 
monoclonal antibody, and quantitation of the 
LCVs that bound both antibodies is shown in 
the merged images and is based on analyses of 
100 LCVs. (F) Farnesylation of AnkB anchors it 
to the LCV membrane. The AnkB proteins were 
immunoprecipitated using anti-AnkB antisera 
and then analyzed by immunoblotting (IB) with 
anti-AnkB followed by antifarnesyl antiserum. 
(G) The FTI-277 blocks localization of AnkB to 
the cytosolic side of the LCV membrane. The 
LCVs were isolated from untreated or 0.5 µM 
FTI-277–treated U937 cells at 1 h after infec-
tion and labeled with anti-AnkB antiserum 
before permeabilization (red). After permeabili-
zation, the LCVs were labeled with anti– 
L. pneumophila monoclonal antibody (green) 
and analyzed by confocal microscopy. Quantifi-
cation is shown in the merged panels, where 
the numbers represent the percentage plus 
standard deviation of LCVs that bound anti-
AnkB before permeabilization. Analyses were 
based on examination of 100 LCVs from triplicate samples. All experiments were performed in triplicate, and representative examples are shown. All the re-
sults in this figure are representative of three independent experiments.JEM VOL. 207, August 2, 2010 
Article
1719
Figure 4.  The CaaX motif of AnkB is essential for polyubiquitination of the LCV and for intracellular bacterial replication. (A and B) Repre-
sentative confocal microscopy images of U937 cells (A) and D. discoideum cells (B) infected with L. pneumophila and examined at 2 h after infection  
for recruitment of polyubiquitinated proteins to the LCV. The U937 and D. discoideum cells were infected with the WT strain, the ankB mutant, and the 
ankB mutant complemented with the WT allele of ankB (ankB/c.ankB) or ankB169C/A (ankB/c.ankB169C/A) allele. Bacteria are labeled with anti-L. pneumophila 
(Lpn) antibody (green), polyubiquitinated (poly UB) proteins are labeled red, and the nucleus is stained blue (DAPI). Arrowheads indicate heavy colocaliza-
tion of polyubiquitin with the LCVs. Numbers in the merged panels are quantitation of the percentage of LCVs positive for recruitment of polyubiquitinated 
proteins, based on the examination of 100 LCVs in triplicate samples. (C and D) Intracellular growth kinetics of L. pneumophila strains in U937 cells (C) or 
D. discoideum (D) infected with the WT strain, the ankB mutant, and the ankB mutant complemented with the WT copy of the ankB or the ankB169C/A 
allele. (E) Translocation of AnkB into U937 cells was determined at 1 h after infection. Strains harbored either empty vector (pCya) or Cya hybrids of RalF, 
AnkB, or AnkB169C/A. The translocation-defective dotA mutant harboring AnkB-Cya was used as a negative control. All experiments were performed three 
times, and representative examples are shown. (C–E) The data are the mean of triplicate samples, and the error bars are the standard deviations.1720 Host farnesylation of a Legionella effector | Price et al.
control, ankB-CyaA, or ankB169C/A-CyaA. The transloca-
tion-defective dotA mutant harboring ankB-CyaA was used 
as a negative control. The data showed that AnkB169C/A was 
translocated into the host cell cytosol similar to native AnkB 
and the RalF effector control (Fig. 4 E).
Host farnesyltransferase is essential for the docking  
of polyubiquitinated proteins to the LCV within 
macrophages and D. discoideum
To determine whether host-mediated farnesylation of AnkB 
was important for polyubiquitination of the LCV, U937 cells 
for  intravacuolar  proliferation  of  L.  pneumophila  within   
human macrophages and D. discoideum.
Translocation of AnkB169C/A into the host cell
To  examine  whether  substitution  of  cysteine  for  alanine   
in  the  C-terminal  CaaX  motif  affected  translocation  of 
AnkB169C/A by the Dot/Icm type IV translocation system, 
we used the calmodulin-dependent adenylate cyclase reporter 
fusion assay using ELISA (Al-Khodor et al., 2008; Sory and 
Cornelis, 1994). The U937 cells were infected for 1 h with 
the WT strain harboring the vector alone, ralF-CyaA as a 
Figure 5.  Chemical inhibition of host FT- blocks recruitment of polyubiquitinated proteins to the LCV and abolishes intravacuolar bacte-
rial replication. (A and B) Representative confocal microscopy images of cells untreated or treated with 0.5 µM FTI-277 for U937 cells (A) and D. discoi-
deum (B). The host cells were infected with the WT strain or the ankB mutant, and recruitment of polyubiquitinated (poly UB) proteins to the LCV was 
examined at 2 h after infection. Bacteria are labeled by anti–L. pneumophila (Lpn) antibody (green), polyubiquitin is labeled red, and the nucleus is stained 
blue (DAPI). Arrowheads indicate heavy colocalization of polyubiquitinated proteins with the LCVs. Numbers in the merged panels are quantitation of the 
percentage of LCVs that colocalized with polyubiquitinated proteins at 2 h after infection, based on the examination of 100 LCVs from triplicate samples. 
(C and D) Intracellular growth kinetics of L. pneumophila strains in cells untreated or treated with and without 0.5 µM FTI-277 for U937 cells (C) or  
D. discoideum (D). The cells were infected with the WT strain, the ankB mutant, and the ankB mutant complemented with the WT copy of the ankB or the 
ankB169C/A allele. The results are representative of three independent experiments performed in triplicate, and error bars represent standard deviation.JEM VOL. 207, August 2, 2010 
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RNAi treatment and examined by microscopic single cell 
analyses for decoration of the LCV by polyubiquitinated pro-
teins. The data showed that in untreated cells and in cells 
treated with a scrambled RNAi control, most LCVs of the 
WT strain were decorated with polyubiquitinated proteins at 
2 and 12 h after infection (Fig. 6 A). However, in cells treated 
with FT-–specific RNAi, most LCVs were not decorated 
with polyubiquitinated proteins at 2 and 12 h after infection, 
similar to the ankB-null mutant (Fig. 6 A and not depicted). 
Collectively, we conclude that farnesylation of AnkB by the 
host  farnesyltransferase  is  indispensable  for  the  biological 
function of the F-box–containing AnkB effector.
Host farnesyltransferase is essential for intracellular 
replication of L. pneumophila and other Legionella species
To  determine  whether  host-mediated  farnesylation  of 
AnkB was required for intracellular replication, U937 cells 
and D. discoideum were pretreated with 0.5 µM of the farnesyl-
transferase inhibitor FTI-277 (Fig. 5, A and B). At the con-
centrations used in our experiments, the FTI-277 inhibitor 
had no detectable effect on bacterial proliferation in vitro (un-
published data). Essentially, similar results were found in U937 
cells (Fig. 5 A) and D. discoideum (Fig. 5 B). After 2- and 12-h 
infection of untreated cells with the WT bacteria, most LCVs 
were decorated with polyubiquitinated proteins (Fig. 5,   
A and B). However, in cells treated with FTI-277, most LCVs 
containing WT bacteria were not decorated with polyubiqui-
tinated proteins at 2 and 12 h, similar to the ankB-null mutant 
in untreated cells (Fig. 5, A and B). Therefore, chemical inhi-
bition of farnesyltransferase in macrophages and in D. discoideum 
results in a loss of biological function of AnkB.
To confirm the chemical approach, we used a genetic ap-
proach to knockdown expression of FT- by RNAi (Fig. 2 G). 
The RNAi-treated HEK293 cells were infected after 48 h of 
Figure 6.  Knockdown of expression of host FT- by RNAi blocks recruitment of polyubiquitinated proteins to the LCV and abolishes intravacuolar 
bacterial replication. (A) Representative confocal images of untreated HEK293 cells or cells treated with FT-–specific or scrambled RNAi control. The cells were 
infected with the WT strain or the ankB mutant bacteria, and recruitment of polyubiquitinated proteins to the LCV was examined at 2 h after infection. Bacteria are 
labeled with anti–L. pneumophila (Lpn) antibody (green), polyubiquitinated (polyUB) proteins are labeled red, and the nucleus is stained blue (DAPI). Arrowheads 
indicate heavy colocalization of the LCVs with polyubiquitinated proteins. Numbers in the merged panels are the percentage of LCVs positive for polyubiquitin plus 
standard deviation, based on the examination of 100 LCVs from triplicate samples. (B) Quantitation by single cell analysis of bacterial replicative phagosomes in 
HEK293 cells at 12 h after infection based on the analyses of 100 infected cells by confocal microscopy and presented as the number of bacteria/cell and the per-
centage of cells harboring a certain number of bacteria. The dotA mutant was used as a negative control. Infected cells from multiple coverslips were examined in 
each experiment. The results are representative of three independent experiments performed in triplicate, and error bars represent standard deviation.1722 Host farnesylation of a Legionella effector | Price et al.
and  D.  discoideum  were  pretreated  with  0.5  µM  of  the 
farnesyltransferase inhibitor FTI-277, and the intracellular 
growth kinetics were measured. The data showed that the 
inhibitor suppressed intracellular proliferation within human 
cells and D. discoideum (Fig. 5, C and D). These results were 
further  confirmed  by  single  cell  analysis  using  confocal   
microscopy (Fig. S3).
To determine whether exploitation of the host farnesyl-
ation was required for intracellular proliferation of other Legio-
nella species, we determined the effect of inhibition of the host 
farnesylation by FTI-277 on intracellular replication of Legio-
nella micdadei, Legionella dumoffii, and two strains of Legionella 
longbeachae. Confocal microscopy was used to determine the 
formation of a replicative vacuole at 12 h after infection at 
a low MOI. Although at 2 h there was a single bacterium in 
most infected cells, the formation of a replicative vacuole at 
12 h was evident for all the strains in untreated cells. However, 
inhibition of the host farnesylation machinery blocked intra-
cellular proliferation for all the strains (Fig. S4). Thus, exploita-
tion of the host farnesylation is exhibited by other Legionella 
species and is likely so for many other intracellular pathogens 
that express CaaX motif–containing proteins (Table S1).
To confirm the chemical approach, we silenced the ex-
pression of FT- by RNAi in HEK293 cells before infection 
by L. pneumophila. Single cell analyses by confocal micros-
copy showed that in FT- RNAi–treated cells, bacterial 
replication was severely inhibited when examined at 12 h   
after infection because most cells harbored a single organism 
(Fig. 6 B). This was in stark contrast to untreated cells or cells 
treated with scrambled RNAi control, in which most cells 
harbored approximately eight WT bacteria (Fig. 6 B). Col-
lectively, these data confirm that host farnesyltransferase is an 
essential enzyme for the biological function of AnkB.
To determine whether inhibition of farnesyltransferase 
altered  trafficking  of  the  LCV,  we  used  confocal  laser- 
scanning microscopy to assess colocalization of the LCV with 
the late endosomal/lysosomal marker LAMP-2 and the lumi-
nal lysosomal enzyme cathepsin D at 2 h after infection of 
U937 cells, using formalin-killed bacteria as a positive con-
trol. The data showed that inhibition of host farnesyltransferase 
did not alter trafficking of the LCV (Fig. S5).
The RCE-1 and ICMT host enzymes are essential  
for the biological function of AnkB
Our aforementioned data have shown the PFT was essential for 
the biological function of AnkB. To determine whether RCE-1 
and ICMT were also required for the biological function of 
AnkB, expression of either of the two proteins was knocked 
down by specific RNAi in HEK293 cells to determine the ef-
fect on localization during ectopic expression (Fig. 7, B and C). 
Figure 7.  RNAi knockdown of ICMT and RCE-1 blocks targeting  
of AnkB to membranes and inhibits the biological function of the 
F-box protein in decorating the LCV by polyubiquitinated proteins.  
(A) Representative confocal microscopy images of untreated HEK293 cells 
or RNAi control–treated or ICMT- or RCE-1–specific RNAi–treated cells 
transfected with 3xFlag-tagged AnkB. The cells were labeled with anti-
Flag antibody (green), whereas the nucleus is stained with DAPI (blue). 
Arrowheads indicate localization of the proteins to the plasma membrane. 
(B and C) RNAi-mediated knockdown expression of RCE-1 and ICMT, re-
spectively. (D) Representative confocal images of untreated U937 cells or 
cells treated with the indicated RNAi. The cells were infected with the WT 
strain, and recruitment of polyubiquitinated proteins to the LCV was ex-
amined at 2 h after infection. Bacteria are labeled with anti–L. pneumophila 
(Lpn) antibody (green), polyubiquitinated (polyUB) proteins are labeled 
red, and the nucleus is stained blue (DAPI). Arrowheads indicate heavy 
colocalization of the LCVs with polyubiquitinated proteins. Numbers in 
the merged panels are the percentage of LCVs positive for polyubiquitin 
plus standard deviation, based on the examination of 100 LCVs from trip-
licate samples. (E and F) RNAi-mediated knockdown expression of RCE-1 
and ICMT, respectively. All the results in this figure are representative of 
three independent experiments.JEM VOL. 207, August 2, 2010 
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dotA translocation-defective mutant. This indicated that re-
cruitment of the host FT-, RCE-1, and ICMT required a 
functional Dot/Icm type IV translocation apparatus (Fig. 8, 
A–C). Interestingly, the ankB mutant exhibited a slight but 
significant (Student’s t test, P < 0.001) reduction in colocal-
ization with host FT- relative to WT bacteria, which was 
reversed by complementation of the ankB mutant with the 
WT ankB allele (Fig. 8, A–C). In contrast, complementation 
of the ankB mutant with the ankB169C/A allele did not re-
store colocalization of the LCV with host FT-, compared 
with the ankB mutant complemented with the WT ankB 
allele (Fig. 8, A–C). Colocalization of the LCVs with the 
host FT- was further confirmed using purified LCVs from 
infected macrophages at 2 h after infection (Fig. S6). This 
indicates that other Dot/Icm-translocated effectors play a 
crucial role in recruiting the host FT-, RCE-1, and ICMT 
to the LCV.
Farnesylation of AnkB is essential for intrapulmonary 
proliferation in the mouse model
To determine whether farnesylation of AnkB was required in 
vivo for intrapulmonary proliferation of L. pneumophila, we in-
fected A/J mice with 106 CFUs of L. pneumophila WT strain, 
Cells transfected with Flag-tagged AnkB showed that RCE-1 
was  essential  for  targeting  AnkB  to  the  plasma  membrane, 
whereas ICMT had a partial role because reduced membrane 
localization was evident in the knocked down cells (Fig. 7 A).
During infection of U937 macrophages by the WT strain, 
knockdown expression of RCE-1 or ICMT (Fig. 7, E and F) 
caused a complete inhibition of the biological function of AnkB 
as a platform for the docking of polyubiquitinated proteins to 
the LCV, whereas the RNAi control had no effect (Fig. 7 D). 
Collectively, the host three enzymes FT-, RCE-1, and ICMT 
are essential for the biological function of AnkB.
Dot/Icm-dependent recruitment of FT-, RCE-1, and ICMT 
with the LCV
The LCV membrane is derived from the ER, which is the 
site for cleavage of the -aaX tripeptide and methylation of 
the farnesylated cysteine of the CaaX motif. This led us to 
examine whether host FT-, RCE-1, and ICMT were re-
cruited to the LCV within macrophages using confocal 
microscopy (Fig. 8, A–C). Strikingly, at 2 h after infection, 
75–85% of the LCVs harboring WT bacteria within macro-
phages  colocalized  with  the  three  host  enzymes  (Fig.  8,   
A–C), compared with 20% of the LCVs harboring the 
Figure 8.  Dot/Icm-dependent colocalization of the LCV with the three enzymes FT-, RCE-1, and ICMT. (A–C) The U937 cells were infected 
with WT, dotA, ankB, ankB/c.ankB, and ankB/c.ankB169C/A bacteria. At 2 h after infection, the cells were labeled with anti–L. pneumophila (Lpn) antibodies 
(green) and anti–FT- (A), anti–RCE-1 (B), or anti-ICMT (C) antibodies (red). Nuclei were stained with DAPI (blue). The cells were analyzed by confocal 
microscopy. Arrowheads indicate colocalization of the respective marker with the LCVs. Quantification is shown in the merged images and represents a 
total percentage of LCVs colocalized with the maker plus standard deviation, based on the examination of 100 cells from triplicate samples. All experi-
ments were performed three times, and representative examples are shown.1724 Host farnesylation of a Legionella effector | Price et al.
(Price et al., 2009). Anchored to the cytosolic face of the LCV 
membrane by host-mediated farnesylation, AnkB functions as a 
platform for the docking of polyubiquitinated proteins to the 
LCV membrane (Price et al., 2009). Therefore, exploitation of 
host farnesylation is the second evolutionarily conserved eukary-
otic machinery exploited by the same effector to enable in-
travacuolar proliferation of L. pneumophila within evolutionarily 
distant hosts (Molmeret et al., 2005; Franco et al., 2009). An-
choring of the bacterial F-box effector to the cytosolic face of 
the pathogen-containing vacuolar membrane is novel among 
the large family of mammalian F-box proteins that are not an-
chored to membranes by farnesylation.
The AnkB F-box effector is the only microbial translo-
cated effector known to be modified by the host cell PFT 
machinery, which is essential for biological function in in-
travacuolar proliferation (Price et al., 2009), which is novel. 
The SifA effector of Salmonella typhimurium is translocated by 
the type III secretion system and is localized to the Salmonella-
induced filaments that connect Salmonella-containing vacu-
oles, but its biological function is not known (Boucrot et al., 
2003; Reinicke et al., 2005). When ectopically expressed 
in transformed epithelial cells, SifA is prenylated by PGGT 
and is targeted to membranes (Boucrot et al., 2003; Reinicke 
et al., 2005). However, prenylation of SifA by PGGT is 
dispensable for its biological function because a sifA substitu-
tion mutant blocked from prenylation is fully competent in 
intracellular proliferation and virulence in the mouse model 
(Reinicke et al., 2005). In contrast, PFT-mediated farne-
sylation of AnkB is essential for its biological function, which 
is novel. Our data show the first example for the role of host 
farnesylation of the bacterial effector in proliferation of the 
pathogen in vivo in the mouse model of the disease. This 
clearly shows a remarkable and intimate microbe–host inter-
action that requires modification of the microbial effector by 
the host enzymes to manifest disease.
Although farnesyltransferase is cytosolic, it is recruited to the 
LCV in a Dot/Icm-dependent manner (Segal et al., 1998; Vogel 
et al., 1998), which may enable local farnesylation of AnkB at 
the LCV membrane that is ER derived (Tilney et al., 2001;   
Kagan and Roy, 2002). Farnesylated proteins often undergo 
further  posttranslational  modifications  at  the  ER  membrane 
RCE-1 and ICMT (Wright and Philips, 2006) to cleave the ter-
minal -aaX tripeptide and methylate the terminal farnesylated 
cysteine residue, respectively. Importantly, the three host en-
zymes are essential for the biological function of AnkB. Because 
all three host enzymes are recruited to the ER-derived LCV and 
AnkB is only detectable in the LCV and not in the cytosol, we 
propose that farnesylation and posttranslational processing of the 
C terminus of the farnesylated AnkB effector occur locally at the 
ER-derived LCV membrane. However, it is also possible that 
undetectable amounts of AnkB traffic to the cytosol before 
anchoring to the LCV membrane. Our data provide the first 
example of an intravacuolar pathogen that hijacks the farnesyl-
ation machinery of the host through bacterial-mediated recruit-
ment of the three host enzymes to the pathogen-containing 
vacuole. Because recruitment of the three host enzymes to the 
the ankB mutant, the ankB mutant complemented with the 
WT ankB allele, or the ankB169C/A allele. There was robust 
intrapulmonary proliferation by the WT strain and the ankB 
mutant complemented with the WT ankB allele (Fig. 9). 
In contrast, there was no detectable intrapulmonary prolifera-
tion for the ankB mutant complemented with ankB169C/A al-
lele (Student’s t test, P < 0.001), which was indistinguishable 
from the ankB-null mutant (Fig. 9). We conclude that farne-
sylation of AnkB is essential for its function in vivo in the 
mouse model of Legionnaires’ disease, which is consistent with 
its indispensable role in intracellular proliferation in vitro.
DISCUSSION
Although numerous bacterial effectors of various intravacuo-
lar pathogens are localized to the pathogen-containing vacu-
olar membrane, the mechanisms are not well known. Our 
data provide a potentially new paradigm for anchoring mi-
crobial effectors to the pathogen-containing vacuolar mem-
brane. We provide several lines of evidence from the host 
and from the microbe sides to confirm that the conserved 
cysteine residue in the CaaX motif of AnkB is farnesylated by 
the host farnesyltransferase, leading to anchoring of AnkB to 
the LCV membranes within evolutionarily distant host cells.
We have recently provided the first demonstration of spe-
cific and mechanistic exploitation of conserved eukaryotic pro-
cesses in amoeba and macrophages by L. pneumophila through 
the Dot/Icm-translocated AnkB effector, which exhibits mo-
lecular and functional mimicry of eukaryotic F-box proteins 
Figure 9.  L. pneumophila expressing the ankB169C/A allele is de-
fective in intrapulmonary proliferation in the A/J mice model of 
Legionnaires’ disease. Three A/J mice for each time point were infected 
with 106 CFUs of L. pneumophila WT strain, the ankB mutant, or the ankB 
mutant complemented with either the WT ankB allele (ankB/c.ankB) or 
with the ankB169C/A allele (ankB/c.ankB169C/A). At each time point, three 
mice were sacrificed, lungs were obtained and homogenized, and dilu-
tions were plated on agar plated for CFU enumeration. The results are the 
mean of three mice/time point. These results are representative of two 
independent experiments. Error bars indicate standard deviation.JEM VOL. 207, August 2, 2010 
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Polyclonal rabbit anti–L. pneumophila antiserum, anti–L. micdadei, or anti– 
L. longbeachae was detected by Alexa Fluor 488–conjugated donkey anti–rabbit 
IgG (Invitrogen). Polyubiquitinated proteins were detected using anti–
polyubiquitin FK1 antibody (1:50 dilution; Enzo Life Sciences, Inc.), fol-
lowed by Alexa Fluor 555–conjugated goat anti–mouse IgM (Invitrogen). 
Anti–FT-, anti–RCE-1, and anti-ICMT were obtained from Santa Cruz 
Biotechnology, Inc. and used at 1:50 dilution. Farnesylation was detected 
with a rabbit antifarnesyl antibody (1:50 dilution; Abcam) followed by Alexa 
Fluor 555-conjugated donkey anti–rabbit IgG (Invitrogen). Alexa Fluor–
tagged  antibodies  against  mouse  IgG  were  used  as  secondary  antibodies   
(Invitrogen). The cells were examined with a laser-scanning confocal micro-
scope (FV1000; Olympus) as we described previously (Price et al., 2009). 
On average, 8–15 0.2-µm serial z sections of each image were captured and 
stored for further analyses using Photoshop CS3 (Adobe).
Infection of A/J mice with L. pneumophila. All animal work in this 
manuscript has been performed after approval by the University of Louisville 
Institutional Animal Care and Use Committee, who follows the US federal 
guidelines for the use and humane handling of animals in research. Female, 
pathogen-free, 6–8-wk-old A/J mice were used for infection by intratra-
cheal inoculation with 50 µl containing the bacterial dose as we described 
previously (Santic et al., 2007; Price et al., 2009). Mice were humanely eu-
thanized at various times, the lungs were removed and homogenized, and 
dilutions were cultured on buffered charcoal yeast extract agar for 72 h as 
described previously (Santic et al., 2007; Price et al., 2009).
Online supplemental material. Fig. S1 shows that ectopically expressed 
3xFlag AnkB localizes to the cell periphery of D. discoideum. Fig. S2 shows 
that farnesylation of the CaaX motif of AnkB by D. discoideum anchors it 
to the cytosolic face of the LCV membrane. Fig. S3 shows that chemical 
inhibition of farnesyltransferase by FTI-277 suppresses intracellular prolif-
eration of L. pneumophila. Fig. S4 shows that chemical inhibition of farne-
syltransferase by FTI-277 suppresses the formation of replicative vacuoles 
by other Legionella species. Fig. S5 shows that chemical inhibition of FT- 
does not alter trafficking of the LCV. Fig. S6 shows Dot/Icm-dependent 
colocalization of FT- to purified LCVs. Table S1 lists putative CaaX 
motif proteins in other bacterial pathogens. Table S2 lists the primers used 
in this study. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20100771/DC1.
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LCV is Dot/Icm dependent, it is likely that other effectors are 
involved in recruitment of at least PFT, whereas ICMT and 
RCE-1 can simply be ER-resident proteins and are components 
of the ER-derived LCV membrane. Our data show that exploi-
tation of host farnesylation is essential for intracellular prolifera-
tion of many other Legionella species. It is likely that other 
intravacuolar pathogens that reside within non-ER or ER- 
derived vacuoles such as Mycobacterium tuberculosis, Salmonella en-
terica, Anaplasma marginale, Bartonella henselae, and Brucella abortus 
may exploit the host farnesylation machinery similar to L. pneu-
mophila to allow farnesylation and anchoring of microbial effec-
tors to the pathogen-containing vacuolar membrane.
MATERIALS AND METHODS
Bacterial  strains,  cell  cultures,  and  infections.  L.  pneumophila  strain 
AA100/130b (BAA-74; American Type Culture Collection) and the isogenic 
mutants dotA, ankB, and complemented ankB mutants were grown as described 
previously (Al-Khodor et al., 2008). The L. longbeachae strains (Asare and Abu 
Kwaik, 2007; Asare et al., 2007) and L. micdadei and L. dumoffii strains (Alli 
et al., 2003) have been previously described. E. coli strain DH5- was used for 
cloning purposes. Maintenance of U937 and HEK293 cells was performed as 
previously described (Price et al., 2009). The D. discoideum WT strain AX2 was 
grown axenically at 24°C in HL5 medium supplemented with 0.6% penicillin-
streptomycin and 20 µg/ml G418 as needed at 22°C, as we described previ-
ously (Price et al., 2009). Infection and intracellular proliferation experiments 
were performed as we described previously (Price et al., 2009). In brief, macro-
phages were infected at a MOI of 10 for 1 h, followed by treatment with   
50 µg/ml gentamicin for 1 h to kill extracellular bacteria. At several time points, 
the cells were lysed, and dilutions were plated on agar plates. Isolation of the 
LCVs was performed as we described previously (Price et al., 2009). Measure-
ment of cAMP in cell lysates for adenylate cyclase fusion assays was performed 
using the Direct Cyclic AMP Enzyme Immunoassay kit (Enzo Life Sciences, 
Inc.), as we described previously (Al-Khodor et al., 2008).
Transfections and inhibitors. Cloning of the 3xFlag-tagged ankB169C/A 
and BAP alleles was performed as described previously (Price et al., 2009), 
using specific primers (Table S2). HEK293 cells were transfected using Fu-
gene HD reagent (Roche), as we described previously (Price et al., 2009). 
The various ankB mutant alleles were used as templates to create 3xFlag fu-
sions in plasmid p3xFlag pDM320 for expression in D. discoideum using spe-
cific primers (Table S2). D. discoideum were transformed by electroporation 
according to standard protocols (Pang et al., 1999), and the cells were grown 
in HL5 containing 20 µg/ml G418.
The inhibitors FTI-277 and GGTI-298 (EMD) were resuspended in 
DMSO + 0.4 mM dithiothreitol and used immediately and were maintained 
in the growth media throughout the experiment. Silencing of FT-, ICMT, 
and RCE-1 by RNAi in HEK293 or U937 cells (Santa Cruz Biotechnology, 
Inc.) was performed as we described previously (Price et al., 2009).
Triton X-114 partitioning, immunoprecipitation, and immunoblot-
ting. Cells were lysed in M-PER reagent (Thermo Fisher Scientific) contain-
ing a protease inhibitor cocktail (Complete Mini EDTA-free; Roche). 
Flag-tagged proteins were purified using anti-Flag M2 resin (Sigma-Aldrich) 
and subjected to immunoblot analysis using an antifarnesyl antibody (1:200 di-
lution; Abcam), anti-Flag antibody (1:1,000 dilution; Sigma-Aldrich), or   
anti-AnkB antisera (1:60,000 dilution). Detection was by enhanced chemilu-
minescence (Thermo Fisher Scientific).
Triton X-114 extractions of transfected HEK293 cells were performed 
as described previously (Reinicke et al., 2005). Both detergent and aqueous 
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